Central Valley Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.04M Sell
4,091
-9
-0.2% -$2.1K 0.27% 72
2026
Q1
$1M Sell
4,100
-175
-4% -$40.8K 0.27% 68
2025
Q4
$885K Buy
4,275
+645
+18% +$128K 0.26% 68
2025
Q3
$673K Buy
3,630
+314
+9% +$53.8K 0.21% 76
2025
Q2
$507K Buy
3,316
+226
+7% +$34.7K 0.17% 88
2025
Q1
$512K Sell
3,090
-1,819
-37% -$285K 0.19% 79
2024
Q4
$710K Sell
4,909
-215
-4% -$33.3K 0.32% 63
2024
Q3
$830K Sell
5,124
-112
-2% -$17.8K 0.47% 52
2024
Q2
$766K Sell
5,236
-264
-5% -$39.3K 0.33% 57
2024
Q1
$870K Sell
5,500
-230
-4% -$36.6K 0.45% 58
2023
Q4
$898K Buy
+5,730
New +$879K 0.53% 61

Other funds holding JNJ

Central Valley Advisors's JNJ Position: Q2 2026 in Review

Central Valley Advisors reduced its Johnson & Johnson (JNJ) stake by 0.22% in Q2 2026, selling an estimated $2.1K and leaving 4,091 shares worth $1.04M. The position accounts for 0.27% of the portfolio, ranked #72.

Central Valley Advisors first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Central Valley Advisors held 4,091 shares of Johnson & Johnson worth $1.04M as of Q2 2026.
  • Central Valley Advisors sold 9 Johnson & Johnson shares in Q2 2026, an estimated $2.1K.
  • Johnson & Johnson made up 0.27% of Central Valley Advisors's portfolio in Q2 2026, its #72 holding.
  • Central Valley Advisors first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Central Valley Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.